Renninger Robert
Insider CIK 2037968 · ATHA VP of Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LONA LeonaBio, Inc. | S Sale | 2026-03-04 | 2026-03-05 | 906 | $5.37 | $4.9K | 15,851 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 3,900 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 3,900 | — | $0 | 16,757 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 297 | $6.88 | $2.0K | 12,857 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 1,236 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 1,236 | — | $0 | 13,154 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-24 | 2025-12-29 | 34,358 | — | $0 | 34,358 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-11-18 | 2026-01-05 | 1,000 | $2.31 | $2.3K | 11,918 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 2,897 | $0.29 | $840 | 109,186 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 12,359 | — | $0 | 12,359 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 12,359 | — | $0 | 112,083 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2025-05-19 | 2025-07-02 | 10,000 | $0.23 | $2.3K | 99,724 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 58,500 | — | $0 | 58,500 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 73,350 | — | $0 | 73,350 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 39,000 | — | $0 | 39,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-12 | 73,350 | — | $0 | 73,350 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 2,881 | $0.56 | $1.6K | 89,724 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 12,359 | — | $0 | 24,718 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 12,359 | — | $0 | 92,605 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-11-18 | 2025-01-03 | 3,651 | $0.55 | $2.0K | 80,246 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 37,077 | — | $0 | 37,077 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 37,077 | — | $0 | 37,077 | SEC↗ |